We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01570036
Recruitment Status : Recruiting
First Posted : April 4, 2012
Last Update Posted : January 29, 2018
Genentech, Inc.
Sellas Life Sciences Group
Information provided by (Responsible Party):
George E. Peoples, Cancer Insight, LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 2019
  Estimated Study Completion Date : June 2020